Clinical Trial

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit

Study acronym: Ger-SP
Recruiting
View on ClinicalTrials.gov →
Summary
This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-07-25; most recent amendment 2026-06-20.
Status change: Not Yet Recruiting → Recruiting 2023-03-08
Trial Details
NCT Number NCT05475574
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Conditions Infection, Hospital
Enrollment 954 participants
Start Date 2023-03-07
Primary Completion 2029-09-07 (estimated)
Study Completion 2029-09-21 (estimated)
Updated on ClinicalTrials.gov 2026-06-24